iFast Diagnostics

Seed
ifastdiagnostics.com Biotech & Healthcare Northampton, United Kingdom
Total Funding $6.4M
Latest Round Undisclosed Seed
Last Announced May 27, 2026
Investors Undisclosed
Decision Makers 2 Verified

About iFast Diagnostics

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Northampton, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website ifastdiagnostics.com
Domain Registered Date Apr 1, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Seed announced

    startupintros.com

  2. Capital Raise

    Raised $6,420,000 · Seed

    startupintros.com

  3. Milestone

    Website domain registered

    ifastdiagnostics.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for iFast Diagnostics.

Funding History

2 Rounds
Seed · May 27, 2026
Seed · Nov 5, 2024

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts